据悉, Sigyn Therapeutics 将于2025年10月21日在LD Micro活动上展示其心脏透析TM技术, 针对心脏病发作和中风风险. Sigyn Therapeutics to present its CardioDialysis™ tech at LD Micro event on Oct. 21, 2025, targeting heart attack and stroke risks.

Sigyn治疗学(OTCQB:SIGY)将出席2025年10月21日在圣地亚哥举行的第19届年度LD微型主要活动,展示其心脏病诊断TM技术,该技术针对与心脏病发作和中风有关的有害脂质和炎症。 Sigyn Therapeutics (OTCQB: SIGY) will present at the 19th annual LD Micro Main Event on October 21, 2025, in San Diego, showcasing its CardioDialysis™ technology, which targets harmful lipoproteins and inflammation linked to heart attacks and strokes. 公司首席执行官Jim Joyce将强调公司的管道,包括ImmunPrepTM,ChemoprepTM和ChemopureTM,旨在提高癌症治疗. CEO Jim Joyce will highlight the company’s pipeline, including ImmunePrep™, ChemoPrep™, and ChemoPure™, aimed at enhancing cancer treatments. 这次活动有大约120家小型上市公司,提供虚拟访问。 The event features around 120 small-cap companies and offers virtual access.